These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2144046)

  • 1. [Interstitial lung diseases. I. Pathomorphological and immunological aspects and the methods of studies].
    Hajduk B; Małecka G; Derentowicz P; Roszkowski W
    Pneumonol Pol; 1990; 58(4-5):263-8. PubMed ID: 2144046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchoalveolar lavage in diffuse interstitial lung diseases].
    Music E; Mermolja M; Debeljak A; Sorli J
    Plucne Bolesti; 1984; 36(1-2):69-72. PubMed ID: 6514849
    [No Abstract]   [Full Text] [Related]  

  • 3. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract.
    Crystal RG; Bitterman PB; Rennard SI; Hance AJ; Keogh BA
    N Engl J Med; 1984 Jan; 310(4):235-44. PubMed ID: 6361563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of bronchoalveolar lavage in the diagnosis of interstitial diseases of the lungs].
    Cynowska B; Jankowski Z; Zbychorski R; Szelezyński K
    Wiad Lek; 1987 Dec; 40(24):1669-72. PubMed ID: 3451601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of immunologic analysis of bronchoalveolar lavage fluid in the study of interstitial pulmonary fibrosis (review of the literature)].
    Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM
    Lab Delo; 1984; (2):67-75. PubMed ID: 6200661
    [No Abstract]   [Full Text] [Related]  

  • 6. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).
    Crystal RG; Bitterman PB; Rennard SI; Hance AJ; Keogh BA
    N Engl J Med; 1984 Jan; 310(3):154-66. PubMed ID: 6361560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphologic studies in fibrosing alveolitis. I. Content of alveolar macrophages and lymphocytes in lung parenchyma in correlation with the duration of the disease].
    Eckert H; Dvorakovskaja IW; Jerochin WW; Chernjakova DN
    Z Erkr Atmungsorgane; 1988; 170(2):167-71. PubMed ID: 3400289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with bronchoalveolar lavage in diffuse interstitial pulmonary disease].
    Sherson DL; Nielsen H; Struve-Christensen E; Petersen BN
    Ugeskr Laeger; 1987 Jul; 149(29):1942-5. PubMed ID: 3433413
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.
    Fireman EM; Ben Efraim S; Greif J; Kivity S; Topilsky MR
    Clin Exp Immunol; 1988 Jul; 73(1):111-6. PubMed ID: 2971484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of bronchoalveolar lavage in interstitial lung diseases.
    Potdar PV; Jain K; Prabhakaran L; Kamat SR
    J Assoc Physicians India; 1989 Jul; 37(7):444-7. PubMed ID: 2693446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis and progressing factors of interstitial pneumonia].
    Sato T; Yoshizawa Y; Hasegawa S
    Nihon Rinsho; 1990 Mar; 48(3):480-5. PubMed ID: 2355479
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoid interstitial pneumonia: findings at bronchoalveolar lavage.
    Ishizaki T; Miyabo S; Koshino T; Fujimura M; Ueda M; Sato H; Kitagawa M
    Eur J Respir Dis; 1985 Aug; 67(2):128-32. PubMed ID: 3876947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportional analysis of respiratory cells obtained by bronchoalveolar lavage.
    Braude AC; Chamberlain DW; Rebuck AS
    Can Med Assoc J; 1982 Jun; 126(12):1401-3. PubMed ID: 7083096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages in bronchoalveolar lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice.
    Nibbering PH; van der Heide A; van Furth R
    J Pathol; 1989 Mar; 157(3):253-61. PubMed ID: 2926565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Properties of inflammatory cells in broncho-alveolar lavage in pulmonary fibrosis].
    Dayer JM
    Schweiz Med Wochenschr; 1986 Sep; 116(37):1245-9. PubMed ID: 3764395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desquamative interstitial pneumonia. Clinical, optic, ultrastructural, histo-immunoligical and enzymatic study of a case].
    Leclerc JP; Maitre F; Zygelman M; Bessade M; Lamotte M; Chomette G; Roujeau J
    Sem Hop; 1978 Mar; 54(5-8):285-94. PubMed ID: 211623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of activated lymphocytes in bronchoalveolar lavage fluid (BALF) from patients with various diffuse interstitial lung diseases].
    Fujimura N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jul; 22(7):552-61. PubMed ID: 6334190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphocyte populations in bronchoalveolar lavage fluid in various interstitial lung diseases].
    Müller S; Kramer H; Bergmann KC; Wiesner B; Grollmuss H; Unger U; Christ R; Eckert H
    Z Erkr Atmungsorgane; 1984; 163(2):140-5. PubMed ID: 6506803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes.
    Mulligan MS; Wilson GP; Todd RF; Smith CW; Anderson DC; Varani J; Issekutz TB; Miyasaka M; Tamatani T
    J Immunol; 1993 Mar; 150(6):2407-17. PubMed ID: 7680691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pulmonary fibrosis--which cell is the culprit?
    Snider GL
    Am Rev Respir Dis; 1983 May; 127(5):535-9. PubMed ID: 6189433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.